QNTM
NASDAQ · Pharmaceuticals
Quantum Biopharma-B Sub Vot
$3.67
+0.01 (+0.27%)
Open$3.66
Previous Close$3.66
Day High$3.83
Day Low$3.52
52W High$28.59
52W Low$2.85
Volume—
Avg Volume8.0K
Market Cap36.53M
P/E Ratio—
EPS$-5.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+158.3% upside
Current
$3.67
$3.67
Target
$9.48
$9.48
$6.03
$9.48 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.95M | 7.61M | 6.92M |
| Net Income | -79,497,567 | 1.84M | 1.19M |
| Profit Margin | -19,353.5% | 24.2% | 17.2% |
| EBITDA | -49,212,447 | 2.64M | 2.30M |
| Free Cash Flow | — | 1.03M | 1.07M |
| Rev Growth | — | +16.6% | +5.5% |
| Debt/Equity | 0.02 | 0.64 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |